Home > Boards > US Listed > Medical - Equipment >

Cytosorbents Corporation (CTSO)

Add CTSO Price Alert      Hide Sticky   Hide Intro
Moderator: Good Sport, Lakersrback
Search This Board: 
Last Post: 5/19/2022 9:02:09 AM - Followers: 242 - Board type: Free - Posts Today: 0

CytoSorbents Corporation is a leader in critical care immunotherapy, specializing in blood purification. Its flagship product, CytoSorb® is approved in the European Union with distribution in 68 countries around the world, as an extracorporeal cytokine adsorber designed to reduce the "cytokine storm" or "cytokine release syndrome" that could otherwise cause massive inflammation, organ failure and death in common critical illnesses. These are conditions where the risk of death is extremely high, yet no effective treatments exist. CytoSorb® is also being used during and after cardiac surgery to remove inflammatory mediators that can lead to post-operative complications, including multiple organ failure. CytoSorbents recently initiated its pivotal REFRESH (REduction in FREe Hemoglobin) 2 trial – a multi-center, randomized controlled, clinical trial intended to support U.S. regulatory approval of CytoSorb for use in a heart-lung machine during complex cardiac surgery to reduce organ injury. CytoSorb® has been used in more than 46,000 human treatments to date. 

CytoSorbents' purification technologies are based on biocompatible, highly porous polymer beads that can actively remove toxic substances from blood and other bodily fluids by pore capture and surface adsorption. Its technologies have received non-dilutive grant, contract, and other funding of nearly $22 million from DARPA, the U.S. Army, the U.S. Department of Health and Human Services, the National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI), U.S. Special Operations Command (SOCOM) and others. The Company has numerous products under development based upon this unique blood purification technology, protected by 32 issued U.S. patents and multiple applications pending, including CytoSorb-XL™, HemoDefend™, VetResQ™, K+ontrol™, ContrastSorb, DrugSorb, and others. For more information, please visit the Company's websites at http://www.cytosorbents.com and http://www.cytosorb.com or follow us on Facebook and Twitter.

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
CTSO News: Statement of Changes in Beneficial Ownership (4) 05/19/2022 03:02:29 AM
CTSO News: CytoSorbents to Present at Two Upcoming Investor Conferences 05/19/2022 03:00:00 AM
CTSO News: Statement of Changes in Beneficial Ownership (4) 05/09/2022 12:16:55 PM
CTSO News: Dawson James Thinks Cytosorbents’ Stock is Going to Recover 05/08/2022 05:05:32 AM
CTSO News: H.C. Wainwright Thinks Cytosorbents’ Stock is Going to Recover 05/04/2022 02:19:11 AM
#27142   NEWS -- CytoSorbents to Present at Two Upcoming Paulness 05/19/22 09:02:09 AM
#27141   Case of the Week andy55q 05/18/22 07:36:43 AM
#27140   Dude, "demands $30 a share"? Get real and biotech48 05/12/22 03:07:39 PM
#27139   Sorry dude. This company is a joke, this ssmmss 05/12/22 09:25:01 AM
#27138   Successful treatment of severe quetiapine intoxication with CytoSorb hemoadsorpt andy55q 05/12/22 06:58:06 AM
#27136   Case of the Week andy55q 05/11/22 06:22:40 AM
#27132   7.44 cents presplit! Pathetic company! eskay1954 05/06/22 03:50:56 PM
#27131   Case of the Week andy55q 05/06/22 08:35:20 AM
#27130   CytoSorbents Reports First Quarter 2022 Results and Revises Good Sport 05/03/22 04:30:55 PM
#27129   Should be viewed positively by the market. Fingers crossed. fantomphan 05/02/22 11:47:54 AM
#27128   NEWS -- CytoSorbents Awarded Preferred Supplier Agreement with Paulness 05/02/22 09:13:12 AM
#27127   I smell a change of forum direction and Lakersrback 05/01/22 03:32:40 PM
#27126   We’d probably be a lot happier if the kjpcrna 04/30/22 01:28:31 PM
#27125   Given our timelines, I think we need a Lakersrback 04/29/22 04:46:10 PM
#27124   Bio, I think you are genuine and, as fantomphan 04/29/22 02:09:25 PM
#27123   Fantomphan, the glass is always half empty biotech48 04/29/22 11:43:52 AM
#27122   One? One patient? All the new hires and fantomphan 04/29/22 09:20:56 AM
#27121   Does it make you feel good to sarcastically Jdizzy 04/28/22 10:14:20 PM
#27120   Gallon of petrol against the price of a Lakersrback 04/28/22 04:45:21 PM
#27119   Not a word from anyone in an effort Cytobeliever 04/28/22 10:56:37 AM
#27118   And not a word from anyone in an Cytobeliever 04/27/22 04:54:16 PM
#27116   Anyone here stupid enough to vote ‘yes’ “To kjpcrna 04/27/22 03:41:34 PM
#27115   Case of the Week andy55q 04/27/22 06:21:30 AM
#27114   I'm thinking Hemo must be real close. Lakersrback 04/26/22 03:57:14 PM
#27113   Laker. Any updates on your Canadian filter company? martys12 04/26/22 11:54:02 AM
#27112   Hey new Director "Jimy", your free shares are fantomphan 04/26/22 11:08:09 AM
#27111   While our stock is down 70% in the fantomphan 04/26/22 10:35:43 AM
#27110   Whatever happened to HemoDefend? Jdizzy 04/25/22 10:31:39 PM
#27109   I'm planning on moving all my CTSO shares Good Sport 04/25/22 12:08:45 PM
#27108   "In light of the fact that shareholders would fantomphan 04/23/22 09:36:38 AM
#27107   You people sound like novice investors. I Lakersrback 04/23/22 08:27:24 AM
#27106   They’re enhancing shareholder; are you blind? Isn’t that kjpcrna 04/22/22 11:24:42 AM
#27105   When does someone in a high position pay fantomphan 04/22/22 10:51:55 AM
#27104   At what shareprice will EVERYONE have had enough fantomphan 04/22/22 09:42:55 AM
#27103   President My Cousin Vinny total compensation $1.177 MILLION. fantomphan 04/22/22 08:51:34 AM
#27102   Cytokine mass balance levels in donation after circulatory andy55q 04/22/22 06:24:32 AM
#27101   Case of the Week andy55q 04/20/22 06:48:40 AM
#27100   NEWS -- CytoSorbents to Report First Quarter 2022 Paulness 04/19/22 08:29:12 AM
#27099   Eskay is back, just as the shorts have biotech48 04/18/22 07:04:51 PM
#27098   Presplit 11.20 cents! eskay1954 04/18/22 11:25:17 AM
#27097   NEWS -- CytoSorbents To Expand Direct Sales of Paulness 04/14/22 08:21:03 AM
#27096   Case of the Week andy55q 04/13/22 06:03:17 AM
#27095   CytoSorb usage in a dual antiplatelet agent treated andy55q 04/13/22 06:00:15 AM
#27094   Fantomphan, I agree that Phamtom of the Opera biotech48 04/10/22 06:35:41 PM
#27093   If your CTSO statement is not severely in fantomphan 04/10/22 10:40:39 AM
#27092   Fantomwind, I am not sucking wind. I am biotech48 04/09/22 07:56:49 PM
#27091   Sadly but not surprising the market didn't care fantomphan 04/09/22 12:57:06 PM
#27090   NEWS -- CytoSorbents Receives Approximately $740,000 from the Paulness 04/07/22 08:09:33 AM
#27089   Case of the Week andy55q 04/06/22 06:56:14 AM
#27088   Amen to that! FDA approval on the radar Good Sport 04/05/22 03:06:26 PM
Consent Preferences